Pharmaceutical industry groups tell the European Commission that while proposed EU GMP Annex I revisions represent an improvement, more work is needed to make them practical to implement. Industry groups want more alignment with other regulatory and compendial cleanroom standards for water for injection (WFI), and cleanroom designations and want to see pre-use/post sterilization integrity testing (PUPSIT) and limits for large particles in cleanroom air eliminated. There are also concerns about the cost of complying.
The European Commission on Dec. 20, 2017, published the proposed Annex 1 revisions, which make significant changes to the EU's...





